hrcak mascot   Srce   HID

Pregledni rad

The polymorphisms in Toll-like receptor genes and cancer risk

ANA GOMAZ ; Ruđer Bošković Institute, Division of Molecular Medicine, Laboratory of Molecular Oncology, Bijenička cesta 54, 10 000 Zagreb, Croatia
JASMINKA PAVELIĆ ; Ruđer Bošković Institute, Division of Molecular Medicine, Laboratory of Molecular Oncology, Bijenička cesta 54, 10 000 Zagreb, Croatia
TANJA MATIJEVIĆ GLAVAN ; Ruđer Bošković Institute, Division of Molecular Medicine, Laboratory of Molecular Oncology, Bijenička cesta 54, 10 000 Zagreb, Croatia

Puni tekst: engleski, pdf (304 KB) str. 461-469 preuzimanja: 1.150* citiraj
APA 6th Edition
GOMAZ, A., PAVELIĆ, J. i MATIJEVIĆ GLAVAN, T. (2012). The polymorphisms in Toll-like receptor genes and cancer risk. Periodicum biologorum, 114 (4), 461-469. Preuzeto s https://hrcak.srce.hr/101207
MLA 8th Edition
GOMAZ, ANA, et al. "The polymorphisms in Toll-like receptor genes and cancer risk." Periodicum biologorum, vol. 114, br. 4, 2012, str. 461-469. https://hrcak.srce.hr/101207. Citirano 23.01.2020.
Chicago 17th Edition
GOMAZ, ANA, JASMINKA PAVELIĆ i TANJA MATIJEVIĆ GLAVAN. "The polymorphisms in Toll-like receptor genes and cancer risk." Periodicum biologorum 114, br. 4 (2012): 461-469. https://hrcak.srce.hr/101207
Harvard
GOMAZ, A., PAVELIĆ, J., i MATIJEVIĆ GLAVAN, T. (2012). 'The polymorphisms in Toll-like receptor genes and cancer risk', Periodicum biologorum, 114(4), str. 461-469. Preuzeto s: https://hrcak.srce.hr/101207 (Datum pristupa: 23.01.2020.)
Vancouver
GOMAZ A, PAVELIĆ J, MATIJEVIĆ GLAVAN T. The polymorphisms in Toll-like receptor genes and cancer risk. Periodicum biologorum [Internet]. 2012 [pristupljeno 23.01.2020.];114(4):461-469. Dostupno na: https://hrcak.srce.hr/101207
IEEE
A. GOMAZ, J. PAVELIĆ i T. MATIJEVIĆ GLAVAN, "The polymorphisms in Toll-like receptor genes and cancer risk", Periodicum biologorum, vol.114, br. 4, str. 461-469, 2012. [Online]. Dostupno na: https://hrcak.srce.hr/101207. [Citirano: 23.01.2020.]

Sažetak
Toll-like receptors (TLRs) are a family of pattern recognition receptors
and have important role in pathogen recognition including activation of
innate and acquired immune responses. They are mainly expressed in
epithelium but have also been found in cancer cells, where they can have
pro-tumorigenic and anti-tumorigenic effect. Single nucleotide polymorphisms (SNPs) may change protein structure and influence receptor function. Polymorphisms in TLR genes have been linked with various cancer types and reports were often contradictory. The strongest association with increased cancer risk was found for TLR2 polymorphism –196 to –174 del (Δ22) (gastric, gallbladder and cervical cancer) and TLR4 polymorphisms rs4986790 (gastrointestinal cancers and lymphoma) and rs4986791 (gastrointestinal cancers, nasopharyngeal and gallbladder cancer). Other polymorphisms
associatedwith cancer risk includeTLR10-TLR1-TLR6 gene cluster
polymorphisms rs10008492 (non-Hodgkin’s lymphoma) and rs7696175
(breast cancer), TLR6 rs5743815 (non-Hodgkin’s lymphoma), TLR10
rs11466657 (meningioma), TLR2 GT microsatellite repeat number polymorphism (colorectal cancer) and rs3804100 (MALT lymphoma), TLR3 829A>C (nasopharyngeal cancer), TLR4 11350G>C (nasopharyngeal cancer), rs1927911 and rs10759931 (prostate cancer), TLR5 rs5744174 (gastric cancer) and TLR9 rs5743836 (Hodgkin’s lymphoma) and rs352140 (Hodgkin’s lymphoma and cervical cancer). Discrepancies in results of different studies regarding TLR polymorphisms and cancer risk may have arissen due to insufficient sample size, differences in ethnicity or age, undetected infections or other environmental factors.

Ključne riječi
Toll-like receptor; polymorphism; cancer; immune response; inflammation

Hrčak ID: 101207

URI
https://hrcak.srce.hr/101207

Posjeta: 1.362 *